Ajaya Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $20M

  • Investors
  • 4

Ajaya Bio General Information

Description

Operator of a biotechnology company intended to precisely eliminate disease-driving cells in autoimmune and cancer. The company is tackling the lack of curative therapies in autoimmune and cancer by developing bispecific antibodies that precisely target and eliminate disease-driving cells, enabling the healthcare sector to transform chronic management into potentially curative treatments.

Contact Information

Website
www.ajaya.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 601 Walnut Street
  • Suite 715
  • Philadelphia, PA 19106
  • United States
+1 (217)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 601 Walnut Street
  • Suite 715
  • Philadelphia, PA 19106
  • United States
+1 (217)

Ajaya Bio Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ajaya Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) $20M Upcoming Startup
4. Early Stage VC 20-Mar-2026 Completed Startup
3. Accelerator/Incubator 05-Dec-2025 Completed Startup
2. Accelerator/Incubator 04-Apr-2025 $450K Completed Startup
1. Angel (individual) 02-Jul-2024 $450K $450K Completed Startup
To view Ajaya Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ajaya Bio Patents

Ajaya Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026178163-A1 Cd23-targeting compositions and uses thereof for improved immunotherapies Pending 18-Feb-2025

Ajaya Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ajaya Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
BioAdvance Capital (Conshohocken) Venture Capital Minority
The Innovation Space Accelerator/Incubator
HiveBio Accelerator/Incubator
To view Ajaya Bio’s complete investors history, request access »

Ajaya Bio FAQs

  • When was Ajaya Bio founded?

    Ajaya Bio was founded in 2024.

  • Where is Ajaya Bio headquartered?

    Ajaya Bio is headquartered in Philadelphia, PA.

  • What is the size of Ajaya Bio?

    Ajaya Bio has 4 total employees.

  • What industry is Ajaya Bio in?

    Ajaya Bio’s primary industry is Biotechnology.

  • Is Ajaya Bio a private or public company?

    Ajaya Bio is a Private company.

  • What is Ajaya Bio’s current revenue?

    The current revenue for Ajaya Bio is .

  • How much funding has Ajaya Bio raised over time?

    Ajaya Bio has raised $1.4M.

  • Who are Ajaya Bio’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania, BioAdvance Capital (Conshohocken), The Innovation Space, and HiveBio have invested in Ajaya Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process